Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 April 1989:
Vol. 244. no. 4903, pp. 471 - 475
DOI: 10.1126/science.2655084

Articles

Science, Vol 244, Issue 4903, 471-475
Copyright © 1989 by American Association for the Advancement of Science


articles

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans

H Lee, P Swanson, VS Shorty, JA Zack, JD Rosenblatt, and IS Chen

Diagnostics Division, Abbott Laboratories, North Chicago, IL 60064.

Confirmed infection with HTLV-II (human T cell leukemia virus type II) has been described only in rare cases. The major limitation to serological diagnosis of HTLV-II has been the difficulty of distinguishing HTLV-II from HTLV-I (human T cell leukemia virus type I) infection, because of substantial cross-reactivity between the viruses. A sensitive modification of the polymerase chain reaction method was used to provide unambiguous molecular evidence that a significant proportion of intravenous drug abusers are infected with HTLV, and the majority of these individuals are infected with HTLV-II rather than HTLV-I. Of 23 individuals confirmed by polymerase chain reaction analysis to be infected with HTLV, 21 were identified to be infected with HTLV-II, and 2 were infected with HTLV-I. Molecular identification of an HTLV-II--infected population provides an opportunity to investigate the pathogenicity of HTLV-II in humans.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND OTHER VIRAL CO-INFECTIONS AMONG YOUNG HETEROSEXUAL MEN AND WOMEN IN ARGENTINA.
M. DE LOS ANGELES PANDO, M. M. BIGLIONE, M. F. TOSCANO, J. A. REY, K. L. RUSSELL, M. NEGRETE, S. GIANNI, L. MARTINEZ-PERALTA, H. SALOMON, S. SOSA-ESTANI, et al. (2004)
Am J Trop Med Hyg 71, 153-159
   Abstract »    Full Text »    PDF »
Prevalence of HTLV infection in pregnant women in Spain.
A. Machuca, C. Tuset, V. Soriano, E. Caballero, A. Aguilera, and R. O. de Lejarazu (2000)
Sex Transm Inf 76, 366-370
   Abstract »    Full Text »    PDF »
Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.
M. Salemi, M. Lewis, J. F. Egan, W. W. Hall, J. Desmyter, and A.-M. Vandamme (1999)
PNAS 96, 13253-13258
   Abstract »    Full Text »    PDF »
Identification of a Domain within the Human T-Cell Leukemia Virus Type 2 Envelope Required for Syncytium Induction and Replication.
B. Poon and I. S. Y. Chen (1998)
J. Virol. 72, 1959-1966
   Abstract »    Full Text »    PDF »
Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2.
S. L. Tarsis, M.-T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks (1998)
J. Virol. 72, 841-846
   Abstract »    Full Text »    PDF »
Variable Immortalizing Potential and Frequent Virus Latency in Blood-Derived T-Cell Clones Infected With Human T-Cell Leukemia Virus Type I.
J.H. Richardson, P. Hollsberg, A. Windhagen, L.A. Child, D.A. Hafler, and A.M.L. Lever (1997)
Blood 89, 3303-3314
   Abstract »    Full Text »    PDF »
Safety of the Blood Supply.
E. M. Sloand, E. Pitt, and H. G. Klein (1995)
JAMA 274, 1368-1373
   Abstract »    PDF »
Clearance of HIV Infection in a Perinatally Infected Infant.
Y. J. Bryson, S. Pang, L. S. Wei, R. Dickover, A. Diagne, and I. S.Y. Chen (1995)
N. Engl. J. Med. 332, 833-838
   Abstract »    Full Text »    PDF »
HIV, HTLV-I, and CD4+ Lymphocytes: Troubles in the Relationship.
P. A. Volberding (1994)
JAMA 271, 392-393
   Abstract »    PDF »
Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection.
P. Hollsberg and D. A. Hafler (1993)
N. Engl. J. Med. 328, 1173-1182
   Full Text »
Idiopathic CD4+ T-Lymphocytopenia -- Immunodeficiency without Evidence of HIV Infection.
D. D. Ho, Y. Cao, T. Zhu, C. Farthing, N. Wang, G. Gu, R. T. Schooley, and E. S. Daar (1993)
N. Engl. J. Med. 328, 380-385
   Abstract »    Full Text »
Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery: A Multicenter Study of HIV-1 and HTLV-I/II Infections.
K. E. Nelson, J. G. Donahue, A. Munoz, N. D. Cohen, P. M. Ness, A. Teague, V. A. Stambolis, D. H. Yawn, B. Callicott, H. McAllister, et al. (1992)
Ann Intern Med 117, 554-559
   Abstract »    PDF »
The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome.
E. Gotuzzo, J. Escamilla, I. A. Phillips, J. Sanchez, F. S. Wignall, and J. Antigoni (1992)
Arch Intern Med 152, 1429-1432
   Abstract »    PDF »
Evidence for Sexual Transmission of Human T Lymphotropic Virus Type II.
B. Hjelle, S. Cyrus, and S. G. Swenson (1992)
Ann Intern Med 116, 90-91
   Abstract »    PDF »
Viruses in human cancers.
H zur Hausen (1991)
Science 254, 1167-1173
   Abstract »    PDF »
Transmission of Human T-Lymphotropic Virus Types I and II by Blood Transfusion: A Retrospective Study of Recipients of Blood Components (1983 Through 1988).
M. T. Sullivan, A. E. Williams, C. T. Fang, T. Grandinetti, B. J. Poiesz, G. D. Ehrlich, and The American Red Cross HTLV-I/II Collaborative Stu (1991)
Arch Intern Med 151, 2043-2048
   Abstract »    PDF »
HTLV Seroreactivity in Italian Intravenous Drug Addicts Is Primarily due to HTLV-II Infection.
O. E. Varnier, F. Lillo, S. S. Alexander, R. M. Forbis, and A. Lazzarin (1991)
JAMA 265, 597
   Abstract »    PDF »
No Evidence for Human T-cell Leukemia Virus Type I or Human T-cell Leukemia Virus Type II Infection in Patients With Multiple Sclerosis.
A. Perl, K. Nagy, T. Pazmany, C. Isaacs, K. Baraczka, T. Szabo, and J. Feher (1990)
Arch Neurol 47, 1061-1063
   Abstract »    PDF »
Failure to Detect Human T-cell Leukemia Virus-Related Sequences in Multiple Sclerosis Blood.
I. S. Y. Chen, A. M. Haislip, L. W. Myers, G. W. Ellison, and J. E. Merrill (1990)
Arch Neurol 47, 1064-1065
   Abstract »    PDF »
Human T-Lymphotropic Virus (HTLV I-II) Infection among Patients in an Inner-City Emergency Department.
G. D. Kelen, T. A. DiGiovanna, L. Lofy, E. Junkins, A. Stein, K. T. Sivertson, M. Lairmore, and T. C. Quinn (1990)
Ann Intern Med 113, 368-372
   Abstract »    PDF »
Seroprevalence and Risk Factors for HTLV-I/II Infection Among Female Prostitutes in the United States.
R. F. Khabbaz, W. W. Darrow, T. M. Hartley, J. Witte, J. B. Cohen, J. French, P. S. Gill, J. Potterat, R. K. Sikes, R. Reich, et al. (1990)
JAMA 263, 60-64
   Abstract »    PDF »
Human T-Lymphotrophic Viruses and Diseases of Long Latency.
W. A. Blattner (1989)
Ann Intern Med 111, 4-6
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)